{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:58:46Z","timestamp":1784224726130,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbr.2019.02.028","type":"journal-article","created":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T15:49:56Z","timestamp":1550332196000},"page":"162-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pharmacological evidence for the relationship between the NMDA receptor and nitric oxide pathway and the antidepressant-like effects of glucagon-like peptide-2 in the mouse forced-swim test"],"prefix":"10.1016","volume":"364","author":[{"given":"Sachie","family":"Sasaki-Hamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Nabeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.02.028_bib0005","doi-asserted-by":"crossref","first-page":"11880","DOI":"10.1016\/S0021-9258(18)67324-7","article-title":"Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing","volume":"261","author":"Mojsov","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.02.028_bib0010","first-page":"342","article-title":"Role of prohormone convertases in the tissue-specific processing of proglucagon","volume":"10","author":"Dhanvantari","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbr.2019.02.028_bib0015","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1073\/pnas.96.4.1569","article-title":"Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2","volume":"96","author":"Munroe","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2019.02.028_bib0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/gast.2000.16489","article-title":"Enteroendocrine localization of GLP-2 receptor expression in humans and rodents","volume":"119","author":"Yusta","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbr.2019.02.028_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ijo.0801912","article-title":"Glucagon-like peptide containing pathways in the regulation of feeding behaviour","volume":"25","author":"Tang-Christensen","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.bbr.2019.02.028_bib0030","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1210\/en.2004-0100","article-title":"Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells","volume":"145","author":"Lovshin","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2019.02.028_bib0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/77535","article-title":"The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake","volume":"6","author":"Tang-Christensen","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbr.2019.02.028_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2012.03.032","article-title":"Immunohistochemical determination of the site of hypotensive effects of glucagon-like peptide-2 in the rat brain","volume":"212","author":"Sasaki-Hamada","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2019.02.028_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbr.2009.06.020","article-title":"Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways","volume":"204","author":"Iwai","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.02.028_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2013.01.010","article-title":"Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice","volume":"243","author":"Iwai","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.02.028_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuroscience.2015.03.010","article-title":"Immunohistochemical determination of the site of antidepressant-like effects of glucagon-like peptide-2 in ACTH-treated mice","volume":"294","author":"Sasaki-Hamada","year":"2015","journal-title":"Neuroscience"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2019.02.028_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2019.02.028_bib0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.bbr.2019.02.028_bib0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2019.02.028_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"1-3","key":"10.1016\/j.bbr.2019.02.028_bib0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2019.02.028_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1601","key":"10.1016\/j.bbr.2019.02.028_bib0090","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","article-title":"A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists","volume":"367","author":"Duman","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2019.02.028_bib0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0165-0173(00)00018-7","article-title":"Roles of NMDA receptor activity and nitric oxide production in brain development","volume":"32","author":"Contestabile","year":"2000","journal-title":"Brain Res. Rev."},{"issue":"5","key":"10.1016\/j.bbr.2019.02.028_bib0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2019.02.028_bib0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1073858410366481","article-title":"Nitric oxide signaling in brain function, dysfunction, and dementia","volume":"16","author":"Steinert","year":"2010","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.bbr.2019.02.028_bib0110","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","article-title":"Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice","volume":"31","author":"Dhir","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbr.2019.02.028_bib0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/phrs.1997.0245","article-title":"Anxiolytic and antidepressant properties of methylene blue in animal models","volume":"36","author":"Ero\u011flu","year":"1997","journal-title":"Pharmacol. Res."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2019.02.028_bib0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2019.02.028_bib0125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.bbr.2019.02.028_bib0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.bbr.2019.02.028_bib0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(02)00312-1","article-title":"Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice","volume":"140","author":"Volke","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.02.028_bib0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.peptides.2016.11.013","article-title":"Antidepressant-like effects exerted by the intranasal administration of a glucagon-like peptide-2 derivative containing cell-penetrating peptides and a penetration-accelerating sequence in mice","volume":"87","author":"Sasaki-Hamada","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2019.02.028_bib0145","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2016.05.035","article-title":"Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test","volume":"82","author":"Ostadhadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.bbr.2019.02.028_bib0150","doi-asserted-by":"crossref","first-page":"E1416","DOI":"10.3390\/ijms18071416","article-title":"Glycine-binding site stimulants of NMDA receptors alleviate extrapyramidal motor disorders by cctivating the nigrostriatal dopaminergic pathway","volume":"18","author":"Shimizu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2019.02.028_bib0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","article-title":"Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test","volume":"225","author":"Moretti","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.02.028_bib0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2014.03.008","article-title":"Antidepressant-like effect of Canavalia brasiliensis (ConBr) lectin in mice: evidence for the involvement of the glutamatergic system","volume":"122","author":"Rieger","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2019.02.028_bib0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.bbr.2019.02.028_bib0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2019.02.028_bib0175","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.pnpbp.2010.06.013","article-title":"The role of glutamate on the action of antidepressants","volume":"35","author":"Hashimoto","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2019.02.028_bib0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2007.04.007","article-title":"Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs","volume":"115","author":"Palucha","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bbr.2019.02.028_bib0185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.febslet.2004.12.056","article-title":"Calmodulin interacts with the cytoplasmic tails of the parathyroid hormone 1 receptor and a sub-set of class b G-protein coupled receptors","volume":"579","author":"Mahon","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbr.2019.02.028_bib0190","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1471-4159.2006.03988.x","article-title":"Nitric oxide cell bioenergetic and neurodegeneration","volume":"97","author":"Moncada","year":"2006","journal-title":"J. Neurochem."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2019.02.028_bib0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bbr.2019.02.028_bib0200","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818314748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818314748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:00:29Z","timestamp":1694628029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818314748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":40,"alternative-id":["S0166432818314748"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.02.028","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological evidence for the relationship between the NMDA receptor and nitric oxide pathway and the antidepressant-like effects of glucagon-like peptide-2 in the mouse forced-swim test","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}